Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.
作者信息
Dao Kim, Chtioui Haithem, Lu Yimin, Peer Cody J, Figg William D, Pruijm Menno, Buclin Thierry, Kissling Sébastien
机构信息
Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
出版信息
Am J Kidney Dis. 2017 Apr;69(4):553-554. doi: 10.1053/j.ajkd.2016.10.026. Epub 2017 Jan 4.
Abstract
摘要
相似文献
1
Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.使用高通量滤器进行血液透析患者的泊马度胺药代动力学
Am J Kidney Dis. 2017 Apr;69(4):553-554. doi: 10.1053/j.ajkd.2016.10.026. Epub 2017 Jan 4.
2
Population pharmacokinetics of pomalidomide.泊马度胺的群体药代动力学。
J Clin Pharmacol. 2015 May;55(5):563-72. doi: 10.1002/jcph.455. Epub 2015 Feb 4.
3
Population Pharmacokinetics and Exposure Response Analysis of Pomalidomide in Subjects With Relapsed or Refractory Multiple Myeloma From the Novel Combination Treatment of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone.泊马度胺、硼替佐米和低剂量地塞米松联合治疗复发/难治性多发性骨髓瘤患者的泊马度胺群体药代动力学和暴露反应分析。
J Clin Pharmacol. 2020 Aug;60(8):1061-1075. doi: 10.1002/jcph.1602. Epub 2020 Mar 13.
4
Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.泊马度胺联合低剂量地塞米松治疗复发/难治性多发性骨髓瘤伴肾功能损害患者的疗效：一项 II 期试验结果。
J Clin Oncol. 2018 Jul 10;36(20):2035-2043. doi: 10.1200/JCO.2017.76.1742. Epub 2018 Feb 2.
5
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data.泊马度胺治疗复发难治性多发性骨髓瘤：生物学和临床数据综述
Expert Rev Anticancer Ther. 2014 May;14(5):499-510. doi: 10.1586/14737140.2014.906904. Epub 2014 Apr 17.
6
Pomalidomide for the management of refractory multiple myeloma.泊马度胺用于难治性多发性骨髓瘤的治疗
Am J Health Syst Pharm. 2014 Sep 1;71(17):1443-8. doi: 10.2146/ajhp130752.
7
Impact of pomalidomide therapy in multiple myeloma: a recent survey.泊马度胺治疗多发性骨髓瘤的影响：一项近期调查
J Chemother. 2014 Dec;26(6):321-7. doi: 10.1179/1973947814Y.0000000201. Epub 2014 Jul 9.
8
Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma.泊马度胺用于骨髓瘤治疗的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1517-27. doi: 10.1517/17425255.2013.827169. Epub 2013 Aug 21.
9
Retroperitoneal relapse in an older patient with multiple myeloma during pomalidomide and dexamethasone treatment.一名老年多发性骨髓瘤患者在泊马度胺和地塞米松治疗期间出现腹膜后复发。
Geriatr Gerontol Int. 2018 Jun;18(6):977-979. doi: 10.1111/ggi.13298.
10
Pomalidomide for multiple myeloma.泊马度胺用于治疗多发性骨髓瘤。
Expert Rev Hematol. 2014 Dec;7(6):719-31. doi: 10.1586/17474086.2014.966074. Epub 2014 Sep 30.
引用本文的文献
1
In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects.在体评估 CYP1A2 抑制和诱导对健康受试者泊马度胺药代动力学的影响。
J Clin Pharmacol. 2018 Oct;58(10):1295-1304. doi: 10.1002/jcph.1145. Epub 2018 May 15.
2
An Open-Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics.一项评估肝损伤对泊马度胺药代动力学影响的开放标签、1 期研究。
Clin Pharmacol Drug Dev. 2019 Apr;8(3):346-354. doi: 10.1002/cpdd.470. Epub 2018 May 10.
本文引用的文献
1
Population pharmacokinetics of pomalidomide.泊马度胺的群体药代动力学。
J Clin Pharmacol. 2015 May;55(5):563-72. doi: 10.1002/jcph.455. Epub 2015 Feb 4.
2
Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.慢性肾脏病及需要透析的患者的药代动力学考量
Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/17425255.2014.931371. Epub 2014 Jun 24.
3
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses.一种用于药代动力学分析的灵敏且稳健的高效液相色谱（HPLC）荧光检测法，用于定量测定人血浆中的泊马度胺。
J Pharm Biomed Anal. 2014 Apr;92:63-8. doi: 10.1016/j.jpba.2014.01.001. Epub 2014 Jan 9.
4
Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma.泊马度胺用于骨髓瘤治疗的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1517-27. doi: 10.1517/17425255.2013.827169. Epub 2013 Aug 21.
5
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration.口服[14C]泊马度胺后在人体内的吸收、代谢和排泄。
Cancer Chemother Pharmacol. 2013 Feb;71(2):489-501. doi: 10.1007/s00280-012-2040-6. Epub 2012 Dec 1.
Zotero 插件